Container Top
Search

Events Calendar

EVENT SEARCH:

In This Section


Most Read Stories


Blogs:


First Bell - On Education:
No City of Akron basketball tonight

Pets:
Pet telethon re-airs

The Heldenfiles:
Chipmunks "Squeakquel" on DVD/BD March 30

Akron Zips:
Late surge gives Zips ugly road win

Tribe Matters:
Blogmail response on Hafner

Cleveland Browns:
Stallworth's contract terminated

Balanced Ledger:
QB in Browns future: another mock draft

Kent State Sports:
KSU Notes – February 9

Cleveland Cavaliers:
NBA Power Rankings from Around the Internet

Buckeye Blogging:
Buckeyes grab 18 players on signing day

Varsity Letters:
Garfield at Buchtel basketball

All Da King's Men:
Palin At The Tea Party Convention

Blog of Mass Destruction:
Republican Pre-Conditions

Akron Law Café:
Citizens United v. F.E.C. (Part 4): Kennedy's and O'Connor's Basic Approaches to Constitutional Decisionmaking – Top Down and Bottom Up

Car Chase:
Collector Car Hobby Loses One of the Best—Jim Roll

Let's Talk Real Estate:
Decisions Decisions: Credit Cards or Your Mortgage?

Ohio Travels with Betty:
Loucile is looking for a Lake Erie getaway in June for three kids, ages 1, 3, and 5.

Sound Check:
Talk of the Town – Top entertainment picks for the weekend

HRLite House:
Track HR Research

Akron Gamer:
Makers of 'Castle Crashers' unveil 'BattleBlock Theater'

See Jane Style:
Do IT this week: Layering

FDA approves Allergan sale of eyelash-thickening agent


Associated Press

Allergan Inc., maker of the wrinkle smoother Botox, won U.S. approval Friday to sell the first prescription medicine to enhance dull or thinning eyelashes.

The Food and Drug Administration cleared the solution, called Latisse, after a unanimous recommendation from its outside advisers, Allergan said.

Latisse contains the same main ingredient as Allergan's Lumigan, on the market for glaucoma since 2001.

The Irvine, Calif., company is targeting Latisse at the $3.7 billion-a-year global market for mascara.

Latisse, chemically known as bimatoprost, is applied to the base of the eyelashes to improve their length, thickness and color.

A glaucoma specialist noticed in 1996 that patients using drugs of the same type, called prostaglandins, grew longer lashes. He patented his finding and licensed it to Allergan.


Get the full article here.


Story tools

Email  Email   Print  Print   Save  Save   Reprint  Reprint   Popular  Most Popular   Reprint  Subscribe

Share this story

AddThis Social Bookmark Button














Most Commented Stories